
Otsuka Hafnor 0.45% Infusion
Marketer
Otsuka Pharmaceuticals Pvt Ltd
Salt Composition
Sodium Chloride (0.45% w/v)
Overview Otsuka Hafnor 0.45% Infusion
Otsuka Hafnor 0.45% Infusion, a sterile saline solution, provides short-term fluid replacement therapy. It addresses hypovolemia stemming from dehydration or trauma by replenishing essential electrolytes and salts. Administration requires the oversight of a qualified healthcare provider. Individuals with known allergies to this infusion should avoid its use. During treatment, your physician may monitor blood pressure and order periodic blood tests. Common side effects include injection site reactions, low blood pressure, fever, trembling, and chills; report any concerning symptoms immediately. Prior to infusion, disclose any pregnancy, breastfeeding, or kidney conditions, as dosage modifications might be necessary. This infusion is generally safe for patients with liver disease.
Uses of Otsuka Hafnor 0.45% Infusion
Managing transient post-trauma fluid deficits | Rehydration therapy
Major Benefits of Otsuka Hafnor 0.45% Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Otsuka Hafnor 0.45% Infusion:
- Injection site reactions (pain, swelling, redness)
- Hypotension (low blood pressure)
- Fever
- Tremors
- Chills
How to use Otsuka Hafnor 0.45% Infusion:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Otsuka Hafnor 0.45% Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Otsuka Hafnor 0.45% Infusion during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of 0.45% Otsuka Hafnor Infusion with breastfeeding are unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Administering Otsuka Hafnor 0.45% Infusion may induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Refrain from operating a vehicle should these effects manifest.
KidneyCAUTION
For patients with kidney impairment, administration of Otsuka Hafnor 0.45% Infusion requires careful monitoring. The dosage of Otsuka Hafnor 0.45% Infusion might require modification. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Otsuka Hafnor 0.45% Infusion appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification for this infusion may be unnecessary in such cases. Physician consultation is advised.
What if you forget to take Otsuka Hafnor 0.45% Infusion :
Omit a dose of Otsuka Hafnor 0.45% Infusion? Seek medical advice.
Facts to Know About Otsuka Hafnor 0.45% Infusion
| Label | Value |
|---|---|
| Chemical Category | Chlorides of Alkali Metals |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
